title: A novel and cost effective method of removing excess albumin from plasma/serum samples and its impacts on LC-MS/MS bioanalysis of therapeutic proteins.
abstract: We have developed an innovative method to remove albumin from plasma/serum samples for the LC-MS/MS quantitation of therapeutic proteins. Different combinations of organic solvents and acids were screened for their ability to remove albumin from plasma and serum samples. Removal efficiency was monitored by two signature peptides (QTALVELVK and LVNEVTEFAK) from albumin. Isopropanol with 1.0% trichloroacetic acid was found to be the most effective combination to remove albumin while retaining the protein of interest. Our approach was compared with a commercial albumin depletion kit on both efficiency of albumin removal and recovery of target proteins. We have demonstrated that our approach can remove 95% of the total albumin in human plasma samples while retaining close to 100% for two of three therapeutic proteins tested, with the third one at 60-80%. The commercial kit removed 98% of albumin but suffered at least 50% recovery loss for all therapeutic proteins when compared to our approach. Using BMS-C as a probe compound, the incorporation of the albumin removal approach has improved both assay sensitivity and ruggedness, compared to the whole plasma protein digestion approach alone. An LC-MS/MS method was developed and validated based on this new approach for the analysis of BMS-C in monkey serum. This assay was successfully applied to a toxicological study. When the albumin removal method was used in another clinical LC-MS/MS method, the sensitivity improved 10-fold to 50 ng/mL LLOQ comparing to a typical pellet digestion method.
authors.affiliation: Bioanalytical Sciences, Research & Development, Bristol-Myers Squibb, Co. ; Route 206 and Province Line Road, Princeton, New Jersey 08543, United States.
authors.forename: Guowen
authors.initials: G
authors.lastname: Liu
authors.forename: Yue
authors.initials: Y
authors.lastname: Zhao
authors.forename: Aida
authors.initials: A
authors.lastname: Angeles
authors.forename: Lora L
authors.initials: LL
authors.lastname: Hamuro
authors.forename: Mark E
authors.initials: ME
authors.lastname: Arnold
authors.forename: Jim X
authors.initials: JX
authors.lastname: Shen
mesh_terms: D000595:Amino Acid Sequence; D005591:Chemical Fractionation / Q000379:methods; D011232:Chemical Precipitation; D002853:Chromatography, Liquid; D006801:Humans; D008969:Molecular Sequence Data; D010455:Peptides / Q000737:chemistry / Q000302:isolation & purification; D044967:Serum / Q000737:chemistry; D012709:Serum Albumin / Q000737:chemistry / Q000302:isolation & purification*; D053719:Tandem Mass Spectrometry
chemical_list: D010455:Peptides; D012709:Serum Albumin